| Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy | Prof Sanjeeva Srivastava, Assistant Professor, Indian Institute of Technology (IIT) Bombay, Dr Om Shrivastav, Director, , Jaslok Hospital, Mumbai, Dr Jayanthi S. Shastri, Professor & Head, T N Medical College & Nair Hospital, Dr Mala Vinod Kaneria, Jaslok Hospital, Mumbai | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| Identifying potential drug targets in the structural proteins of SARS-Cov-2 | Dr Thenmalarchelvi, Associate Professor, Indian Institute of Technology (IIT) Hyderabad | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| IND enabling studies and development of CDRI-4655 as anti-hyper-triglyceridemic formulation | Dr Anil Nilkanth Gaikwad, Scientist, CSIR-Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences |
| Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy | Dr Sanjeeva Srivastava, Professor, Indian Institute of Technology (IIT), Mumbai | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | COVID-19 Research, Life Sciences & Biotechnology, Pharmaceutical Sciences |
| Development of some mammalian cell based models to screen potent leads that might inhibit viral infection | Prof Partha Roy, Indian Institute of Technology (IIT) Roorkee | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| Indian spices and medicinal plants as antiviral against COVID-19 and other related viruses | Prof Vikash Kumar Dubey, Professor, Indian Institute of Technology (IIT), Varanasi | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| Designing virus-like particles as vaccine candidates against nCoV-19 Proposed express M (Membrane), N (Nucleocapsid), E (Envelope) and S (Spike) proteins of nCoV-19 simultaneously in HEK293 cells for generating virus-like particle | Prof Manidipa Banerjee, Indian Institute of Technology (IIT) Delhi | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| Identifying Possible Potent Inhibitors against COVID-19 via Computational Drug Repurposing Study | Dr Parimal Kar, Assistant Professor, Indian Institute of Technology (IIT) Indore | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| A Novel Herbal Product for Vulvovaginal Candidiasis | Dr B.N. Singh, Senior Scientist, CSIR-National Botanical Research Institute (CSIR-NBRI), Lucknow | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Medical Sciences, Pharmaceutical Sciences |
| Working on mRNA/peptide-based vaccine for SARS-Cov-2 | Dr Jyotsnendu Giri, Assistant Professor, Indian Institute of Technology (IIT) Hyderabad | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |